ACTUActuate Therapeutics Inc. Common stock
1.270USD+19.81%Mkt Cap: 30.50M $P/E: —3d ago
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synth…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap30.50M $
Enterprise Value25.11M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-22.23M $
Revenue/Share—
Last Price1.270 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.70
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.61
EPS (TTM)-1.01
EPS (Forward)-0.72
52W Range
0.90004% of range9.220
52W High9.220 USD
52W Low0.9000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-280.51%
ROA-158.36%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.21M $
CapEx (TTM)—
FCF Margin—
FCF Yield-40.89%
Net Debt-4.43M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.25
Quick Ratio1.16
Book Value/Sh0.3410 USD
Cash/Share0.1840 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)10.01 USD
Upside (mean)+688.4%
Target Range5.000 USD – 15.05 USD
$5.000+688.4% to mean$15.05
# Analysts4
Ownership
Shares Out.24.01M
Float8.60M
Insiders15.41%
Institutions56.32%
Short Interest
Short Ratio1.1d
Short % Float4.30%
Short % Out.1.88%
Shares Short450.18K
Short (prev mo.)687.10K
Technical
SMA 501.430 (-11.2%)
SMA 2003.568 (-64.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)364.14K
Avg Vol (10d)270.13K
Technical Indicators
RSI (14)53.2
MACD-0.1062
MACD Signal-0.1407
MACD Hist.+0.0345
BB Upper1.281 USD
BB Middle1.098 USD
BB Lower0.9151 USD
BB Width33.32%
ATR (14)0.1512 USD
Vol Ratio (20d)1.50x